Wellman, Inc. v. Eastman Chemical Co.

642 F.3d 1355, 98 U.S.P.Q. 2d (BNA) 1505, 2011 U.S. App. LEXIS 8903, 2011 WL 1601994
CourtCourt of Appeals for the Federal Circuit
DecidedApril 29, 2011
Docket2010-1249
StatusPublished
Cited by37 cases

This text of 642 F.3d 1355 (Wellman, Inc. v. Eastman Chemical Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wellman, Inc. v. Eastman Chemical Co., 642 F.3d 1355, 98 U.S.P.Q. 2d (BNA) 1505, 2011 U.S. App. LEXIS 8903, 2011 WL 1601994 (Fed. Cir. 2011).

Opinion

RADER, Chief Judge.

The United States District Court for the District of Delaware granted Eastman Chemical Company’s (“Eastman’s”) motion for summary judgment of invalidity of U.S. Patent Nos. 7,129,317 (the “'317 patent”) and 7,094,863 (the “'863 patent”) (collectively, the “Wellman patents”) for indefiniteness and granted-in-part Eastman’s motion for summary judgment of invalidity for failure to disclose the best mode. Because the specifications of the Wellman patents do not set forth the best mode of carrying out the invention contemplated by at least one of the inventors, this court affirms the district court’s judgment with respect to best mode. Because a person of ordinary skill could understand the bounds of the patent claims, however, this court reverses the district court’s judgment with respect to indefiniteness.

I

The Wellman patents disclose polyethylene terephthalate (“PET”) resins for use in plastic beverage containers. The patents claim priority to the same applications and share similar specifications. The patents state that prior art PET resins produced bottles that shrank or grew hazy from crystallization when “hot-filled” with product at temperatures of between about 180° C and 205° C. '317 patent col.2 11.1-9; '863 patent col.2 11.9-17. To overcome these problems, the Wellman patents disclose “slow-crystallizing” PET resins that purportedly retain exceptional clarity by delaying the onset of crystallization relative to conventional PET resins. '317 patent col.3 11.15-25; '863 patent col.3 11.25— 35. The disclosed resins also purportedly reduce haze formed during the production process. '317 patent col.8 11.39-47; '863 patent col.3 11.46-54.

The Wellman patents define “slow-crystallizing” PET resins as those possessing a significantly higher heating crystallization exotherm peak temperature (TCH) as compared with conventional PET resins, which use the metallic element antimony as a catalyst. '317 patent col.3 11.16-20; '863 patent col.3 11.25-30. TCH is the temperature at which the sample crystallizes the fastest during heating in a differential scanning calorimetry (“DSC”) machine. '317 patent eol.7 11.55-58, col.8 11.48-53; '863 patent col.7 11.62-65, col.8 11.55-65. Thus, Figure 1 of each patent shows a slow-crystallizing, titanium-catalyzed PET resin with a Tca of 144.2°C. By comparison, Figure 3 shows a conventional antimony-catalyzed PET resin with a TCH of 130.6°C. '317 patent col.8 11.7-22; '863 patent col.811.14-29.

By the time Wellman filed the application leading to the '317 patent in May 2004, it had commercialized a slow-crystallizing, hot-fill PET resin called TÍ818. According to Dr. Steven Nichols, an inventor *1358 of the Wellman patents, TÍ818 had the following composition as of May 2004:

Parameter Amount

Isophthalic Acid 1.4 mol %

Diethylene Glycol 1.9 mol %

Trimellitic Anhydride (“TMA”) 500 ppm

Carbon-Black reheat agent 7.5 ppm

Elemental Cobalt 30 ppm

Titanium-based catalyst 7 ppm (Ti)

Phosphorus 5 ppm

Potassium 25 ppm

Wellman did not disclose the recipe for TÍ818 in its patents. Nor did Wellman disclose any other specific PET resin recipes. Instead, Wellman provided ranges of concentrations for categorized lists of possible ingredients. For example, the patents, identify a preferred range of isophthalic acid, a raw ingredient used to synthesize PET, of between about 1.6 and 2.4 mole percent. '317 patent eol.20 1.65-col.211.2; '863 patent col.22 11.30-34. Ti818 contained 1.4 mole percent isophthalic acid. Similarly, the Wellman patents identify a preferred concentration of 1.6 mole percent for diethylene glycol, another raw ingredient used to synthesize PET. '317 patent col.20 1.65-col.21 1.2; '863 patent col.22 11.30-34. TÍ818 contained 1.9 mole percent diethylene glycol.

The Wellman patents disclose optional heat-up rate (“HUR”) additives for the PET resin that improve the resin’s reheating profile during bottle blow molding. '317 patent col.10 11.16-26; '863 patent col.ll 11.38-49. The patents state that “natural spinels and synthetic spinels” are the “most preferred” HUR additives. '317 patent col.ll 11.42-43; '863 patent col.12 11.64-65. Copper chromite black spinel and chrome iron nickel black spinel are characterized as “[particularly outstanding spinel pigments.” '317 patent col.ll 11.42-47; '863 patent col.13 11.1-2. In contrast, the Wellman patents describe carbon-based HUR additives as “one embodiment” of the invention. '317 patent col.ll 11.1-2; '863 patent col.12 11.23-24. The patents state that “suitable” carbon-based additives include carbon black, and note that U.S. Patent No. 4,408,004 (“Pengilly”) discloses “satisfactory” carbon black HUR additives. '317 patent col.ll 11.8-12; '863 patent col.12 11.30-34. Pengilly discloses a preferred average particle size for carbon black in a range of between about 15 to about 30 nm. Pengilly col.4 11.21-22. Well-man’s Ti818 recipe includes a HUR additive called N990, which is a specific type of carbon black with a 290 nm particle size.

Notably, two provisional applications in the chain of applications leading to the Wellman patents, respectively filed May 21, 2003 and April 6, 2004, characterize carbon-based HUR additives as “preferable]” and copper chromite spinels as “suitable.” On May 20, 2004, the day before Wellman filed the nonprovisional application leading to the '317 patent, Well-man filed a third provisional application changing its preference from a carbon-based HUR to a spinel.

Claim 1 of the '317 patent is representative of the asserted claims and states as follows:

1. A polyethylene terephthalate resin, comprising:
less than about 25 ppm of elemental antimony, if any; and more than about 5 ppm of elemental phosphorus; and
wherein the polyethylene terephthalate resin has a heating crystallization ex-otherm peak temperature (TCH) of more than about lfO° C. at a heating rate of 10° C. per minute as measured by differential scanning calorimetry;
*1359 wherein the polyethylene terephthalate resin has an absorbance (A) of at least about 0.18 cm-1 at a wavelength of 1100 nm or at a wavelength of 1280 nm; and
wherein the polyethylene terephthalate resin has an L* luminosity value of more than about 70 as classified in the CIE L*a*b* color space.

'317 patent col.26 11.9-23 (emphasis added). All of the asserted claims include TCH limitations.

Wellman alleges that Eastman directly infringes claims 1-5, 7, 8, 11-14, 16-21, 24, 32, 33, 36, 38, 39, 44, 93, 94, 96-102, and 104 of the '317 patent. Wellman further alleges that Eastman indirectly infringes claims 1, 3-6, 8, 9, 11, 15, 17, 24, and 62 of the '863 patent.

On August 14, 2009, Eastman moved for summary judgment of invalidity on the grounds of indefiniteness and failure to set forth the best mode of practicing the claimed invention.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Terracino v. Trimaco, Inc.
E.D. North Carolina, 2024
Basf Corporation v. Johnson Matthey Inc.
875 F.3d 1360 (Federal Circuit, 2017)
Uusi, LLC v. United States
131 Fed. Cl. 244 (Federal Claims, 2017)
American Innotek, Inc. v. United States
126 Fed. Cl. 468 (Federal Claims, 2016)
HSM Portfolio LLC v. Elpida Memory Inc.
160 F. Supp. 3d 708 (D. Delaware, 2016)
Akzo Nobel Coatings, Inc. v. Dow Chemical Company
811 F.3d 1334 (Federal Circuit, 2016)
The Dow Chemical Company v. Nova Chemicals Corporation
809 F.3d 1223 (Federal Circuit, 2015)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
789 F.3d 1335 (Federal Circuit, 2015)
Ddr Holdings, LLC v. hotels.com, L.P.
773 F.3d 1245 (Federal Circuit, 2014)
Procter & Gamble Co. v. Team Technologies, Inc.
46 F. Supp. 3d 764 (S.D. Ohio, 2014)
Interval Licensing LLC v. Aol, Inc.
766 F.3d 1364 (Federal Circuit, 2014)
3m Innovative Properties v. Tredegar Corporation
725 F.3d 1315 (Federal Circuit, 2013)
Anvik Corporation v. Nikon Precision, Inc.
519 F. App'x 1019 (Federal Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
642 F.3d 1355, 98 U.S.P.Q. 2d (BNA) 1505, 2011 U.S. App. LEXIS 8903, 2011 WL 1601994, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wellman-inc-v-eastman-chemical-co-cafc-2011.